Berg LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Berg LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10580
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Berg LLC (Berg) is a biopharmaceutical company that focus on therapeutic discovery using AI-based Interrogative biology platform. The company’s proprietary platform Interrogative Biology, combines patient biology and artificial intelligence-based analytics to understand predictive patterns on diseases. Its pipeline products include BPM 31510 and BPM 31543. Berg’s platform identifies therapies and biomarkers by applying algorithm and probability-based artificial intelligence to analyze large numbers of patient’s genotypic, phenotypic, and other characteristics. The company carries out research and development of diagnostics, theranostics and patient therapeutics in the areas of oncology, endocrinology and neurology. Its analytics engine enables health plans, EHR vendors, providers, and clinical decision support organizations to plan, implement and measure interventions. Berg is headquartered in Framingham, Massachusetts, the US.

Berg LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Berg LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Berg LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Berg LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Berg LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Berg LLC, Medical Devices Deals, 2012 to YTD 2018 9
Berg LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Berg LLC, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
BERG, Massachusetts General Hospital and Brigham and Women’s Hospital Enter into Research Agreement 11
Berg Enters into Research Agreement with Sanofi 12
BERG Enters into Research Partnership with AstraZeneca 13
BERG Enters into Research Agreement with Department of Defense and Walter Reed National Military Medical Center 14
BERG Partners with Parkinson’s Institute and Clinical Center 15
Berg To Enter Into Agreement With Medical University Of South Carolina For Lupus Biomarker Discovery 16
Berg Enters Into Drug Discovery And Development Agreement With Icahn School Of Medicine 17
Berg Pharma Enters Into R&D Agreement with U.S. Department of Defense For Prostate Cancer Biomarker Discovery 18
Berg Pharma Enters Into Co-Development Agreement With Parkinson’s Institute 19
Berg LLC – Key Competitors 20
Berg LLC – Key Employees 21
Berg LLC – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Corporate Communications 23
Feb 07, 2017: BERG Announces Appointment of Titus Plattel as Chief Operating Officer 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Berg LLC, Pharmaceuticals & Healthcare, Key Facts 2
Berg LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Berg LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Berg LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Berg LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Berg LLC, Medical Devices Deals, 2012 to YTD 2018 9
Berg LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BERG, Massachusetts General Hospital and Brigham and Women’s Hospital Enter into Research Agreement 11
Berg Enters into Research Agreement with Sanofi 12
BERG Enters into Research Partnership with AstraZeneca 13
BERG Enters into Research Agreement with Department of Defense and Walter Reed National Military Medical Center 14
BERG Partners with Parkinson's Institute and Clinical Center 15
Berg To Enter Into Agreement With Medical University Of South Carolina For Lupus Biomarker Discovery 16
Berg Enters Into Drug Discovery And Development Agreement With Icahn School Of Medicine 17
Berg Pharma Enters Into R&D Agreement with U.S. Department of Defense For Prostate Cancer Biomarker Discovery 18
Berg Pharma Enters Into Co-Development Agreement With Parkinson's Institute 19
Berg LLC, Key Competitors 20
Berg LLC, Key Employees 21

List of Figures
Berg LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Berg LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Berg LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Berg LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Berg LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Berg LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Berg LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Berg LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Berg LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Berg LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Reliance Communications Ltd (RCOM):企業の財務・戦略的SWOT分析
    Reliance Communications Ltd (RCOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Arris International Plc
    Arris International Plc - Strategy, SWOT and Corporate Finance Report Summary Arris International Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • E-CO Energi Holding AS:企業の戦略的SWOT分析
    E-CO Energi Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Tandem Diabetes Care Inc (TNDM):企業の製品パイプライン分析2018
    Summary Tandem Diabetes Care Inc (Tandem) is a medical device company that designs, develops and manufactures diabetic care products. The company provides products such as t:slim X2 insulin pump, t:slim G4 insulin pump, t:flex insulin pump, t:simulator demo app, software and apps, t:connect applicat …
  • SMU S.A. (SMU):企業の財務・戦略的SWOT分析
    SMU S.A. (SMU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Wells Fargo & Co (WFC):企業の財務・戦略的SWOT分析
    Wells Fargo & Co (WFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Xerium Technologies Inc:企業の戦略的SWOT分析
    Xerium Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • WEC Energy Group:企業の戦略・SWOT・財務分析
    WEC Energy Group - Strategy, SWOT and Corporate Finance Report Summary WEC Energy Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Akers Biosciences Inc (AKER):製薬・医療:M&Aディール及び事業提携情報
    Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRO …
  • Ternium SA:戦略・SWOT・企業財務分析
    Ternium SA - Strategy, SWOT and Corporate Finance Report Summary Ternium SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Vivendi SA (VIV):企業の財務・戦略的SWOT分析
    Vivendi SA (VIV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cadence Design Systems, Inc. (CDNS):企業の財務・戦略的SWOT分析
    Cadence Design Systems, Inc. (CDNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Nezavisni operator sustava u Bosni i Hercegovini:企業の戦略的SWOT分析
    Nezavisni operator sustava u Bosni i Hercegovini - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • Concur Technologies Inc:企業の戦略的SWOT分析
    Concur Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Medline Industries, Inc.:企業の戦略・SWOT・財務分析
    Medline Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Medline Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Kalle GmbH:企業の戦略的SWOT分析
    Kalle GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Oiltanking GmbH-石油・ガス分野:企業M&A・提携分析
    Summary Oiltanking GmbH (Oiltanking), a subsidiary of Marquard & Bahls AG is an independent tank storage service provider. The company offers storage facilities and associated services for oils, petroleum products, chemicals, biofuels, gases and dry bulk. It owns and operates terminals in Europe, No …
  • Moneygram International, Inc.:企業のM&A・事業提携・投資動向
    Moneygram International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Moneygram International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • CH2M HILL Companies, Ltd.:企業の戦略・SWOT・財務情報
    CH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report Summary CH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Luna Innovations Inc (LUNA):企業の製品パイプライン分析
    Summary Luna Innovations Inc (Luna) is an optical technology development company that research, develops and commercializes speed optics and fiber optic test products. The company provides products such as fiber optic sensing products, fiber optic test and measurement products, high speed optical pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆